BioElectronics Corporation BIEL
OTC PK
| 12/31/2021 | 09/30/2021 | 06/30/2021 | 03/31/2021 | 12/31/2020 | |
|---|---|---|---|---|---|
| Revenue | 1.61M | 1.95M | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.61M | 1.95M | -- | -- | -- |
| Cost of Revenue | 814.00K | 882.40K | -- | -- | -- |
| Gross Profit | 795.50K | 1.07M | -- | -- | -- |
| SG&A Expenses | 604.90K | 995.90K | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.75M | 2.24M | -- | -- | -- |
| Operating Income | -137.10K | -291.50K | -- | -- | -- |
| Income Before Tax | -289.90K | -270.90K | -- | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.29 | -0.27 | -- | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -289.90K | -270.90K | -- | -- | -- |
| EBIT | -137.10K | -291.50K | -- | -- | -- |
| EBITDA | -- | -194.60K | -- | -- | -- |
| EPS Basic | 0.00 | 0.00 | -- | -- | -- |
| Normalized Basic EPS | 0.00 | 0.00 | -- | -- | -- |
| EPS Diluted | 0.00 | 0.00 | -- | -- | -- |
| Normalized Diluted EPS | 0.00 | 0.00 | -- | -- | -- |
| Average Basic Shares Outstanding | 97.03B | 97.15B | -- | -- | -- |
| Average Diluted Shares Outstanding | 97.03B | 97.15B | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |